TCRT - Alaunos Therapeutics, Inc.
3.61
0.205 5.679%
Share volume: 25,767
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$3.40
0.21
0.06%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-14-2024 | 05-15-2025 | 08-14-2025 | 11-14-2025 | |
| Total revenue | 1.000 K | 4.000 K | 0.000 | 2.000 K | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 1.000 K | 4.000 K | 0.000 | 2.000 K | 0.000 | 0.000 | |
| 300.00% | -100.00% | inf% | -100.00% | nan% | |||
| Operating expenses | 1.743 M | 1.170 M | 1.150 M | 1.094 M | 1.039 M | 1.187 M | |
| Selling general and admin | 1.617 M | 990.000 K | 1.007 M | 747.000 K | 854.000 K | 718.000 K | |
| Research and development | 126.000 K | 180.000 K | 143.000 K | 347.000 K | 185.000 K | 469.000 K | |
| Total expenses | 1.743 M | 1.170 M | 1.150 M | 1.094 M | 1.039 M | 1.187 M | |
| -32.87% | -1.71% | -4.87% | -5.03% | 14.24% | |||
| Operating income | -1.742 M | -1.166 M | -1.150 M | -1.092 M | -1.039 M | -1.187 M | |
| Ebit | -1.682 M | -1.129 M | -1.127 M | -1.073 M | -1.051 M | -1.159 M | |
| Pretax income | -1.682 M | -1.129 M | -1.127 M | -1.073 M | -1.051 M | -1.159 M | |
| -32.88% | -0.18% | -4.79% | -2.05% | 10.28% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -1.682 M | -1.129 M | -1.127 M | -1.073 M | -1.051 M | -1.159 M | |
| 32.88% | 0.18% | 4.79% | 2.05% | -10.28% |